Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Essential Tremor | 8 | 2024 | 157 | 3.530 |
Why?
|
Parkinson Disease | 23 | 2024 | 2877 | 2.520 |
Why?
|
Deep Brain Stimulation | 14 | 2019 | 832 | 2.120 |
Why?
|
Movement Disorders | 4 | 2023 | 459 | 1.450 |
Why?
|
Parkinsonian Disorders | 4 | 2023 | 284 | 1.370 |
Why?
|
Dyskinesias | 2 | 2023 | 79 | 1.180 |
Why?
|
Subthalamic Nucleus | 4 | 2014 | 195 | 1.100 |
Why?
|
Activities of Daily Living | 2 | 2024 | 2421 | 0.950 |
Why?
|
Chorea | 1 | 2023 | 79 | 0.820 |
Why?
|
Tremor | 2 | 2019 | 191 | 0.550 |
Why?
|
Lymphocytes | 1 | 2024 | 2612 | 0.530 |
Why?
|
Neurology | 3 | 2023 | 780 | 0.460 |
Why?
|
Pedunculopontine Tegmental Nucleus | 1 | 2013 | 17 | 0.430 |
Why?
|
Ventral Thalamic Nuclei | 1 | 2013 | 43 | 0.430 |
Why?
|
Verbal Behavior | 1 | 2014 | 335 | 0.410 |
Why?
|
Voice Training | 1 | 2012 | 44 | 0.390 |
Why?
|
Neutrophils | 1 | 2024 | 3767 | 0.380 |
Why?
|
Speech Disorders | 1 | 2012 | 180 | 0.370 |
Why?
|
Levodopa | 3 | 2023 | 221 | 0.320 |
Why?
|
Antiparkinson Agents | 3 | 2023 | 184 | 0.320 |
Why?
|
Brain Abscess | 1 | 2009 | 120 | 0.310 |
Why?
|
Voice Disorders | 1 | 2012 | 286 | 0.310 |
Why?
|
Psychotherapy, Group | 1 | 2012 | 413 | 0.300 |
Why?
|
Cognition Disorders | 1 | 2022 | 3980 | 0.300 |
Why?
|
Dementia | 1 | 2022 | 2689 | 0.290 |
Why?
|
Dyskinesia, Drug-Induced | 3 | 2015 | 165 | 0.280 |
Why?
|
Thalamus | 1 | 2013 | 1047 | 0.270 |
Why?
|
Quality of Life | 3 | 2024 | 13367 | 0.260 |
Why?
|
Gait Disorders, Neurologic | 2 | 2019 | 240 | 0.260 |
Why?
|
House Calls | 2 | 2017 | 161 | 0.240 |
Why?
|
Neuropsychological Tests | 4 | 2024 | 7054 | 0.240 |
Why?
|
Motor Activity | 1 | 2014 | 2715 | 0.220 |
Why?
|
Monitoring, Ambulatory | 3 | 2011 | 354 | 0.210 |
Why?
|
Gait | 2 | 2019 | 814 | 0.210 |
Why?
|
Aged | 23 | 2024 | 169310 | 0.180 |
Why?
|
Ataxia | 1 | 2023 | 306 | 0.180 |
Why?
|
Humans | 48 | 2024 | 761596 | 0.180 |
Why?
|
Middle Aged | 23 | 2024 | 220921 | 0.170 |
Why?
|
Acceleration | 2 | 2011 | 189 | 0.170 |
Why?
|
Aged, 80 and over | 12 | 2024 | 58984 | 0.160 |
Why?
|
rho-Associated Kinases | 1 | 2021 | 281 | 0.160 |
Why?
|
Electrodes, Implanted | 2 | 2014 | 840 | 0.160 |
Why?
|
Alzheimer Disease | 4 | 2024 | 8601 | 0.160 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2578 | 0.160 |
Why?
|
Brain Mapping | 3 | 2019 | 6635 | 0.160 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2019 | 62 | 0.160 |
Why?
|
Cerebral Infarction | 1 | 2003 | 983 | 0.150 |
Why?
|
Male | 29 | 2024 | 360846 | 0.150 |
Why?
|
High-Intensity Focused Ultrasound Ablation | 1 | 2018 | 40 | 0.150 |
Why?
|
Football | 1 | 2023 | 503 | 0.140 |
Why?
|
Heterozygote | 1 | 2024 | 2787 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3889 | 0.140 |
Why?
|
Nortropanes | 1 | 2016 | 12 | 0.140 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2023 | 1068 | 0.130 |
Why?
|
Magnetic Resonance Angiography | 1 | 2003 | 1432 | 0.130 |
Why?
|
Torticollis | 1 | 2016 | 64 | 0.130 |
Why?
|
Female | 26 | 2024 | 392705 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2024 | 1163 | 0.130 |
Why?
|
Atlases as Topic | 1 | 2017 | 248 | 0.130 |
Why?
|
Antigens, Nuclear | 1 | 2015 | 184 | 0.120 |
Why?
|
Walking | 2 | 2019 | 1198 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14608 | 0.120 |
Why?
|
Physicians | 2 | 2017 | 4591 | 0.110 |
Why?
|
Patient Compliance | 1 | 2024 | 2690 | 0.110 |
Why?
|
Disease Progression | 4 | 2023 | 13510 | 0.110 |
Why?
|
Brain | 6 | 2019 | 27121 | 0.110 |
Why?
|
Videoconferencing | 1 | 2016 | 203 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2024 | 15843 | 0.110 |
Why?
|
Remote Consultation | 1 | 2016 | 237 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 925 | 0.110 |
Why?
|
Microelectrodes | 1 | 2014 | 306 | 0.100 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2015 | 290 | 0.100 |
Why?
|
Tourette Syndrome | 1 | 2015 | 395 | 0.100 |
Why?
|
Speech Therapy | 1 | 2012 | 57 | 0.100 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3713 | 0.090 |
Why?
|
alpha-Synuclein | 1 | 2016 | 750 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2021 | 64685 | 0.080 |
Why?
|
Computer Communication Networks | 1 | 2010 | 293 | 0.080 |
Why?
|
International Cooperation | 1 | 2015 | 1422 | 0.080 |
Why?
|
Telemetry | 1 | 2010 | 199 | 0.080 |
Why?
|
Neuromuscular Agents | 1 | 2010 | 147 | 0.080 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2009 | 173 | 0.080 |
Why?
|
Radiosurgery | 1 | 2018 | 1342 | 0.080 |
Why?
|
Exercise | 1 | 2024 | 5890 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2024 | 80647 | 0.070 |
Why?
|
Nerve Net | 1 | 2019 | 2291 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20100 | 0.070 |
Why?
|
Home Care Services | 2 | 2011 | 648 | 0.070 |
Why?
|
Actigraphy | 1 | 2011 | 520 | 0.070 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2072 | 0.070 |
Why?
|
Botulinum Toxins, Type A | 1 | 2010 | 237 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2650 | 0.070 |
Why?
|
Telemedicine | 2 | 2017 | 3052 | 0.070 |
Why?
|
Adult | 11 | 2024 | 221210 | 0.070 |
Why?
|
Brain Injuries | 1 | 2018 | 2054 | 0.070 |
Why?
|
Cognition | 4 | 2024 | 6992 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26129 | 0.060 |
Why?
|
Clothing | 3 | 2011 | 97 | 0.060 |
Why?
|
Quinolones | 1 | 2009 | 378 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3271 | 0.060 |
Why?
|
Pilot Projects | 2 | 2024 | 8633 | 0.060 |
Why?
|
Internet | 3 | 2016 | 3093 | 0.060 |
Why?
|
Electromyography | 1 | 2010 | 1394 | 0.060 |
Why?
|
Time Factors | 4 | 2017 | 39969 | 0.060 |
Why?
|
Biosensing Techniques | 1 | 2011 | 650 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2024 | 5247 | 0.060 |
Why?
|
Drug Administration Routes | 1 | 2003 | 150 | 0.050 |
Why?
|
Skin | 1 | 2016 | 4484 | 0.050 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2003 | 325 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3322 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18255 | 0.050 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2023 | 415 | 0.050 |
Why?
|
ADP Ribose Transferases | 1 | 2021 | 90 | 0.050 |
Why?
|
Acute Disease | 2 | 2019 | 7237 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10090 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 485 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30053 | 0.040 |
Why?
|
Botulinum Toxins | 1 | 2021 | 189 | 0.040 |
Why?
|
Research Personnel | 1 | 2023 | 588 | 0.040 |
Why?
|
Piperazines | 1 | 2009 | 2523 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2016 | 14665 | 0.040 |
Why?
|
Medical Records | 1 | 2023 | 1408 | 0.040 |
Why?
|
Universities | 1 | 2023 | 993 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36426 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9610 | 0.040 |
Why?
|
Tissue Plasminogen Activator | 1 | 2003 | 1164 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2024 | 2696 | 0.040 |
Why?
|
Movement | 2 | 2015 | 1478 | 0.030 |
Why?
|
Stroke | 1 | 2018 | 9758 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41495 | 0.030 |
Why?
|
Software | 1 | 2010 | 4434 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2009 | 3067 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2019 | 22176 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 2021 | 980 | 0.030 |
Why?
|
Electroencephalography | 1 | 2010 | 6237 | 0.030 |
Why?
|
Postural Balance | 1 | 2019 | 622 | 0.030 |
Why?
|
Language | 1 | 2023 | 1543 | 0.030 |
Why?
|
Taiwan | 1 | 2015 | 521 | 0.030 |
Why?
|
Qualitative Research | 1 | 2024 | 3025 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15266 | 0.030 |
Why?
|
User-Computer Interface | 2 | 2010 | 1400 | 0.030 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2016 | 269 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2003 | 2084 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7968 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4920 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 23996 | 0.020 |
Why?
|
Boston | 1 | 2024 | 9327 | 0.020 |
Why?
|
Social Class | 1 | 2019 | 2004 | 0.020 |
Why?
|
United States | 3 | 2019 | 72340 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2979 | 0.020 |
Why?
|
Temporal Muscle | 1 | 2010 | 36 | 0.020 |
Why?
|
Central Nervous System | 1 | 2017 | 1336 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 22174 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2023 | 39106 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 554 | 0.020 |
Why?
|
Transducers | 1 | 2010 | 244 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2011 | 847 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5035 | 0.020 |
Why?
|
Neural Pathways | 1 | 2018 | 3060 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 8002 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12341 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9001 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36193 | 0.020 |
Why?
|
Caregivers | 1 | 2017 | 2238 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10508 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3462 | 0.010 |
Why?
|
Child, Preschool | 2 | 2019 | 42232 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3358 | 0.010 |
Why?
|
Carcinoma | 1 | 2015 | 2330 | 0.010 |
Why?
|
Equipment Design | 1 | 2011 | 3511 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2017 | 4331 | 0.010 |
Why?
|
Young Adult | 2 | 2021 | 59260 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7828 | 0.010 |
Why?
|
Dopamine | 1 | 2009 | 1607 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12973 | 0.010 |
Why?
|
Animals | 3 | 2019 | 168475 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12990 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74213 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12794 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88326 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
Prospective Studies | 1 | 2003 | 54423 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81539 | 0.010 |
Why?
|
Child | 1 | 2015 | 80158 | 0.000 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_